|
 |
||
      |
|
|
» Apply for a Grant
- FAQs - Young Investigator - Independent Investigator - Distinguished Investigator - Staglin Award » Grantee List - Young Investigators - Independent Investigators - Distinguished Investigators - Staglin Awards
» Prizes
- Lieber Prize - Falcone Prize - Ruane Prize - Goldman-Rakic Prize - Freedman Award - Klerman Award » For Grantees - Young Investigator Fact Sheet - Independent Investigator Fact Sheet - Distinguished Investigator Fact Sheet - Staglin Award Fact Sheet 
|
 Project Summary  Eric A. Storch, Ph.D. (Young Investigator 2007) of University of Florida, will initiate a study using the compound D-Cyclosporine to augment therapy for children with obsessive-compulsive disorder (OCD). Exposure and response prevention therapy has shown efficacy for OCD treatment, but not for all children treated. In the process of neurotransmission, through which nerve cells communicate, the NMDA glutamate receptor is involved in learning and memory. Evidence suggests that D-Cycloserine acts on the receptor to augment associative learning and extinction during exposure-based therapy. Program Area: ANXIETY DISORDERS\Obsessive Compulsive Disorder (OCD) |
Announcements
NARSAD Award Winners
Latest News from NARSAD
|
Mei Huang, Ph.D., Vanderbilt University Medical Center, 2005 & 2007 Young Investigator